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Introduction 
Science and technology policy-making and the study of its effects on innovation are 
requiring a “more sophisticated understanding of the ways on which science and 
technology interact” (to quote, as an example, N. Rosenberg, Science and Public Policy, 
vol 18, number 6, pages 335-346, 1991). 
 
The exploration of these relations has been and continues to be at the core of the models 
that, along the period initiated after the Second World War, have been used to promote 
and analyse the science and technology activities and their outcomes. The “science 
model” left pace to the “science push-market pull – R&D model”, inspired on linearity, 
a model that represented the technological change leading to innovation as closely 
dependent and based essentially on scientific results. More recently, after 
acknowledgement of the insufficiencies of the linear model, models have evolved 
considering that science and technology  and innovation are part of a system, a “social” 
system, whose essential activity is learning and which is also “dynamic”. 
 
This orientation has corresponded with the idea that biology, and not physics, ought to 
inspire the economics of technology and innovation (application of the theory of 
Darwinian evolution, see for a review, J. Mokyr, Bulletin of Economic Research, vol 43, 
number 2, pages 127-149, 1991). The microeconomics view has been at the onset of 
recognising the limitations of the dominant neoliberal theory based on the concept of a 
stable and unique equilibrium. An important lesson that has been learned from the use 
of evolutionary, biology based, models is that history – and culture – matters. As Mokyr 
has stated (see reference cited above)  “... It is simply impossible to understand long-
term economic growth without some kind of Schumpeterian theory of technological 
creativity and innovation. The neoclassical equilibrium paradigm seems singularly 
unsuited to that task”. 
 
 
Evaluation and its limits 
In spite of this discourse, the indicators and methods applied to evaluate science and 
technology outputs and their effects on innovation, are still, and mainly, based on the 
concept of linearity. The bibliometric methods used to measure scientific production 
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and its technological counterpart, i.e. scientific articles and patents, are looking to 
productivity, whereas the economical and human resources devoted to science and 
technology are being seen as the inputs to the system. This output/input model of 
evaluation is leaving aside any assessment of the interactions between science, 
technology and innovation and their actors, and may present limitations to the use of 
econometric models, since they can not take into account the role of human actions and 
influences in the process as well as the influence of cultural values and of the 
environment. However, citation and referencing data have been used in some emerging 
fields (biotechnology and bioscience) to detect the links between science and 
technology (Narin and Noma, Scientometrics, vol 7, Nos 3-6, pages 361-381). The 
situation seems to need an alternative. We have attempted such an alternative by using a 
sociological – historical (analytical-descriptive) approach. The methodology has found 
grounds in a biological (biochemical) metaphor that addresses the dissection of a 
programme (identification of its structure) and how this correlates to the function 
(activities funded, links and influences with the environment). The methodology is 
based on the use of quantitative techniques through surveys addressed to the main actors 
of the research and technology activities (the main researchers and/or the managers of 
the projects). The most relevant point of this approach rests, not on the use of survey, 
but on the type of survey: its structure and configuration. 
 
 
1. The general frame of reference. A European view 
 
The application of methods and practices to evaluate the public policies and their 
programmes addressed to the attainment of goals is experiencing a phase of great 
expansion and experimentation. The European Union and the Commission are 
contributing in a decisive manner to this type of exercises in such a way that this is 
forming a position towards the support by the Member States to the evaluation exercises 
as a means for gaining rationality in the process of making decisions or to frame the 
launching of the respective actions. 
 
There are nevertheless relevant differences between the European countries with respect 
to tradition and intensity in the evaluation practices corresponding to the realm of public 
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policies and programmes. The North European countries possess greater experience in 
the use of evaluation practices as an instrument for the process of making decisions. In 
this context, it is worth to mention the relevant role played by the main actors involved 
in the management of the programmes themselves. Other countries like Belgium, the 
north of Italy and several regions of France are beginning to consider the evaluation as a 
"help system" for the planning and management of the public intervention. This 
development is matching with the put into practice of a series of European programmes 
of socio-economical nature and significance like the Structural Funds Programme and 
several programmes of Control and Regulation. In the great majority of the Southern 
European countries, the evaluation practices are still being considered as a single 
regulatory imposition that constrains the process of decision making, what implies a 
limited influence on the political arena. In many cases, the relevance of the evaluation 
practices in these "less-developed"  countries, in terms of evaluation capacity and skill, 
is even more limited by the absence of quantitative (or able to be measured) objectives 
as well as by the deficits in an information of quality, which are necessary factors for 
the attainment of good results in the evaluation exercises. The work performed through 
the drive and support of the European Union/Commission has allowed the identification 
of a series of factors and components deemed necessary to carry out evaluation 
activities with enough quality and appropriateness to monitor and assess programmes 
which are running or just have ended. They are the following: 
1) analysis of the capacity to absorb the economic resources of the programme while it 
is going on; 
2) identification of the tangible products obtained as compared with the foreseen ones; 
3) analysis of the efficiency of the programme (i.e. assessment of the costs of unit of 
product); 
4) evaluation of the impact; 
5) evaluation of the impact in socio-economical terms; and 
6) identification of the hurdles that are against the success of the initiative. 
 
From them, the evaluators may provide adequate data and proposals to evolve further 
evaluation processes and to give recommendations with regard to issues related to 
organisation and to the reallocation of resources, according to an eventual 
reprogramming. 
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The lack of adequate information may hamper the quality, in-depth  and relevance of 
the processes of analysis and evaluation. Therefore, the Public Administrations share 
the responsability for establishing effective systems of follow-up and providing the 
information with sufficients levels of quality and extent. 
 
 
1.1 Procedures for the evaluation of programmes 
 
The prevailing trend in the evaluation of programmes, mainly of socio-economical 
characteristics, follows alternative approaches. In the first place, the "bottom-up" 
approach is applied with the aim of collecting and valuing information at the projects 
level in order to process and integrate it into the analysis of the programme. As the 
number of projects is usually high, this approach enforces upon the selection of a 
sample. An advantage of this approach is that it allows the gathering of information by 
means of surveys and interviews on the results and impacts of every project. 
 
The analysis of the impact requires statistical data and information. The existence of 
data bases may allow the performance of longitudinal studies based on the history of 
each case in view of correlating the results of the programme with the basic objectives. 
When the data base is lacking, several other methods, as for example the focal groups, 
can be used, but taking into account that the building of good control groups is a pre-
requisite to value the programme and its effectively. The second approach looks to the 
"top-down" analysis which does not imply to reckon to samples and permits to process 
the information with a high level of aggregation. This approach is based on the data that 
are afforded by the respective agencies, though additional instruments such as case 
studies or in-depth studies are needed to gather detailed information with respect to the 
projects. 
 
It is also possible to employ a mix or dual approach combining the "bottom-up" and 
"top-down" lines. This blended system of analysis seems best suited to carry out more 
complete evaluation exercises and thus, it is adequate for the application to the "ex-
post" assessment of programmes or for their follow - up according to a thematic 
perspective. In any one of these approaches, the existing shortcomings in information, 
as it can be obtained from the official reports and sources, can be overcome by 
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additional sources of information from the clients, actors or managers of the 
programmes. To this end, the evaluation exercises rest on in-depth analyses, surveys, 
interviews, protocols and questionnaires aimed to get the opinions and reactions of these 
actors, any one of these instruments having been used in view of the characteristics of 
each programme or of the availability of well checked information. 
 
 
1.2 The research and development (R&D) programmes. Their special traits 
 
All the outlined methodology has been applied to the evaluation of programmes of 
socio-economical natures. The challenge is to adapt these procedures and instruments to 
the R&D programmes which are holding specific properties and characteristics when 
compared to socio-economical programmes. Some of them are: 
• The influence of R&D activities on economy and society is long ranging; those 
activities act in an interactive and indirect way with socio-economy. 
• The input economical indicators used are essentially macro-economical ones such as 
the percentage of Gross Domestic Product devoted to R&D activities as well as the 
number of human resources employed in those activities. They are distributed in 
three (macro) subsectors: Government, Higher Education and Business. Any 
correlation of these "top-down" informations and data with "bottom-up" actions is 
extremely difficult. 
The indicators of production and results ("output") relate mainly to the dynamics of 
the scientific community - research publications and documents concerned with /the 
dissemination of knowledge and, eventually, with its protection rights (patents). 
There are no indicators of economic outputs with the exception of data on the 
technological balance ("degree of sufficiency"). 
• The functioning of R&D programmes is shaped by the sociological and behavioral 
patterns of the scientific community. 
• The R&D programmes and the agencies involved in the management of the 
programmes are run and controlled by scientists and technologists who are acting in 
their double capacity as clients and managers and then are involved in a series of 
processes of interaction and feed-back. 
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• In the R&D programmes, there is a frequent mix of the levels of planning and 
management, unlike what occurs with the socio-economical programmes. There is 
scanty information on the relevance of the role of those agencies with respect to 
these two levels of intervention. 
 
 
2. A specific model to evaluate R&D programmes 
 
The philosophy of biology provides with grounds to analyse and assess the activities 
linked with the development of science and technology from the perspectives of the 
social sciences. I have resorted to this strategy to explore, from the point of view of the 
evolutive biology, the relationships between the life technologies and  their socio-
economical implications (Muñoz 1997). 
 
Following the theoretical lines of the evolutive biologist Ernest Mayr (1982), I have 
coined the term biología operativa ("Operational biology") to integrate the notions of 
structural and  functional biology (Muñoz, 1994) as to confront the evolutive biology 
notion. The "operational biology" offers, in my opinion, the possibility to propose a 
model for the evaluation of R&D programmes which is rooted in the process of cellular 
transduction. The model ("transducing model") as depicted in fig. 1 offers the following 
advantages and analytical possibilities. 
1. It allows to distinguish (and assess) the different steps or levels of action in R&D 
programmes. 
a) Planning level which corresponds to the political domain on which the objectives 
are defined and established. 
b) Management and funding level which operate in the allocation of economical 
resources through the intervention of the agencies. Two paths are possible: path 1, 
where the objectives are passively diffused to the agency (A) that is acting as 
transmitter and controller. In path 2, the agency (A' ) is not receiving targeted 
objectives and, therefore, becomes a transducer which allocates resources through 
experts committees. 
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Political domain
(goals , objectives )
Agency (resources )
Actors - experts
Clients
(projects , grants)
Publications
Effects (impact ) on the system
Relation with socio- economic problems
Effect on users
Products
B ´C C
D D
A A´
C´
D´
Path 1 Path 2
Committees
(2) Analogy : Cell function
Relationships and regulations
      Coupling Structures Actors
Function Clients
(3) Methodology :
            Separation of the parts (different elements ) and analysis of the results .
Possible integration
Figure 1.- The “transducing “ model of R&D programmes
(1)
B
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c) Level of programme execution, on which the expert-actors and the clients-
beneficiaries are interacting. In path 1, there are two types of actors: the experts 
("peers") and burocrats (B) who are allocating resources in relation to the pre-
established goals to the clients (receptors) as groups (C) or individuals (D). In path 
2, the experts are acting within the function of agency A' , whereas the clients - 
beneficiaries are represented in rectangle B' and they will receive grants - in aid, 
fellowships as collectives (C´) or individuals (D' ) to perform research activities in a 
complex institutional and operational environment. 
d) Level of production with the products poured in the scientific-technical "milieu" 
recorded in the statistics of the respective agencies or poured into the external 
"milieu" (society in broad terms). The assessment of the products deriving from path 
1 needs to be carried out in fragmented way ( from the experts and clients) while in 
the case of path 2, the analysis of the products requires a more complex and 
integrated way (from the agency and the different types of actors). 
e) "Feed-back" level that applies to any of both paths and that influences the future 
decisions at every level of the programme. 
 
2. The model attempts to make an analogy of the research programmes with the 
functioning of the cell where there is a coupling between structure and function. 
This analogy eases the process of evaluation by measuring the global or partial 
results of the programme and by identifying the variables: the independent such as 
the coupling  between the parts or processes of the programme and the dependent 
ones such as the composition of the experts committees ("structure") or the 
interactions between the experts and the clients ("regulation"). 
3. The model allows the separation of the parts or elements of the programme driving 
to a reductionist methodology for the analysis or leading to an integrative view from 
the analysis of the parts, in an analogous manner to the methods applied in the 
biochemical analysis. 
The conceptual frame of this methodological approach stems in the significance of the 
microlevel of analysis to understand the relations between the top-down and the bottom-
up approaches to the proposals and actions of the main agents of the science and 
technology system. It runs parallelisms with the philosophy that led, in a different order 
of things, to the application of technology assessment (TA), the instrument that during 
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the decades of seventies and eighties helped to the process of decision–making in the 
emergence of a goal–oriented model of technology programme. Various models of 
technology assessment can be distinguished depending on the mediation between 
science, politics and the general public: the “instrumental model”, the “elitist model”, 
the “participative model”. Our methodology is not purely related to that of TA, but it 
borrows some characteristics to the first two models: the instrumental and the elitist 
ones, whereas it shows its independent nature because our methodology is used to the 
“ex-post” evaluation of science and technology programmes (and processes), whereas 
the T.A. aims to assess “ex – ante” the appreciation of the eventual consequences of the 
scientific and technological developments and programmes. (Bechmann, Science and 
Public Policy, vol. 20, number 3, pages 11-16). 
 
 
3. Examples of Evaluation Exercises. Case Studies 
 
We have attempted to introduce and develop the culture of evaluation of research and 
development programmes by carrying out a series of evaluations on various R&D 
programmes and/or innovative technologies or sectors. Through these exercises the 
rationale was to combine an interesting research agenda with a possible use of the 
results by the policymakers and managers of the R&D activities. The subjects of study 
were selected by applying a series of criteria: 
• They must hold academic, scientific and technological relevance; 
• They should reflect, whenever this were possible, the demands from bodies of the 
Administration; 
• They should represent an important share of the resources allocated by the agencies 
involved; 
• They should be attacked after a good scientific, cognitive and managerial 
background from the team (at least from one of its members) involved in the 
evaluation; 
• They should constitute a relevant contribution to the innovation patterns of Spain 
(emerging technologies, important socio-economical topics) and to the conomic 
wealth of the country or of any of its regions. 
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3.1 National Programmes from the National R&D Plan 
 
The National R&D Plan was the instrument established by the Law for Promotion and 
General Coordination of the Scientific and Technical Research (referred popularly as 
the "Law for Science", Law 13/1986). The idea underlining the establishment of the 
Plan was to coordinate research from a "top-down" approach making recourse to the 
option of planning through objectives and goals fixed by the political authority where 
the different actors should play the game. 
 
For obvious reasons, some programmes of the National R&D Plan were good canditates 
as subjects of evaluation. Applying the criteria outlined before, the following 
programmes, all belonging to the first National R&D Plan extending from the period 
1988-1992 (93), were selected: New Materials, R&D on Pharmaceuticals and Health. 
 
 
3.1.1. The New Materials National Programme 
 
The evaluation was based on a mixed approach using official information from the 
agencies (see below) and a survey addressed to the principal investigators of the 
research projects funded by the programme. A complex text on the results of the 
exercise has been published as a Documento de Trabajo (Working Paper) by Espinosa 
de los Monteros et al.(1994). 
 
The purpose of the current analysis is to provide an overview of those results as filtered 
by the "transducing" model lens. 
 
The driving force for the evaluation exercise was the research interests of the CSIC 
team who presented a project to the National Plan for its funding. The project was 
approved and funded. Thus suggesting some interest from the Administration. 
 
The instruments for the evaluation were analysis of the information gathered from 
official sources and a postal survey addressed to 431 principal investigators (54 per cent 
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from universities, 35 per cent from CSIC and the remaining 11 per cent from semi-
public organism associations from firms and government interface organisations). 
 
 
a) Structural Characteristics 
• The programme was targeted with predetermined priority lines, expressed in broad 
terms but well suited from the technical point of view. 
• The main Agency responsible for the management of the programme was the 
Secretariat of the National R&D Plan with specific action on the research projects 
and on infrastructure and accompanying measures. 
 
The Centre for Technological and Industrial Development (CDTI) was the agency 
involved in the management of the industrially oriented projects ("proyectos 
concertados" which are collaborative projects between public sector research centres 
and industries and "proyectos de desarrollo tecnológico" implemented by the 
industries alone). 
 
The involvement of the two agencies can be assimilated to path 1 according to the 
model of fig. 1. 
 
b) Results (the operational functioning) 
 
b-1) The regional distribution of the resources was gathered from the data provided by 
the main Agency. The results summarised as follows indicate an uneven and quite 
peculiar profile. 
- Main share corresponding to percentages higher than 10 per cent: Madrid 
(42.2%) and Cataluña (15.7%). 
- Medium share corresponding to percentages between 5 and 10 per cent: Aragón 
(9.4%), País Vasco (8.9%), Comunidad Valenciana (7.4 per cent) and 
Andalucia (5.5%). 
 
b-2) The conclusions about the products of the programme are: 
• Relevant contribution to the building and development of a scientific community 
able to compete both internationally (publications increased in number and 
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importance in internationally refereed journals) and nationally  (the researches were 
granted of staff-tenured positions in universities and CSIC). 
• Mismatch between the scientific objectives and the industrial ones. Researchers 
from the public sector pursued publications and training of personnel with low 
applicability of their research even in those projects identified as "applied 
research". On the other hand, projects from the 11 per cent of the other organisms 
revealed a low degree of scientific productivity but a high rate of applicability in 
their results. 
• Contribution to the establishment of good infracture and well equipped laboratories. 
• Formation of a well trained, highly skilled personnel. This result has led to a 
paradoxical situation: this personnel is excessive for the socio-economical demand 
but its offer is insufficient for the scientific and technical needs. 
• All the users of the programme seem to be satisfied but definition of success and 
estimation of satisfaction was different for the most important groups of actors; 
researchers and industrialists. The effects of the programme on the users apperared 
to be divergent depending on the users´ affiliation. 
 
 
3.1.2   The National Programme on R&D on Pharmaceuticals 
 
The rationale underlying the evaluation followed the same pattern as that indicated for 
the Materials Programme. The same driving force and the same instruments supported 
the evaluation of the programme on pharmaceutical research and development. 
 
The evaluation was based in the analysis of the information provided by the agencies 
involved in the management of the programme and in a survey addressed to a universe 
of 124 principal investigators of the research projects (80.6 per cent from universities, 
18.5 per cent from CSIC and 1 from a hospital located in Barcelona). This distribution 
shows already a marked difference with respect to he New Materials Programme as the 
R&D on Pharmaceuticals programme appears strongly linked to university reserach. 
 
A complete text on the evaluation of the programme has been published as Working 
Paper in Espinosa de los Monteros et al. (1995 a). 
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a) Structural Characteristics 
 
• The programme was targeted with a general goal and several specific aims of 
general nature as well as with ten technological objectives. 
 
The general aim of the programme was to foster and coordinate the R&D activities 
of the publics sector and the firms  operating in the pharmaceutical area, one of the 
leading sectors in business R&D expenditure but unable to compete satisfactorily in 
a global world. The specific aims were still quite general such as: the promotion of 
pharmaceutical research to increase its size and excellence; the establimment and 
maintenance of an adequate infrastructure; the training of personnel both in Spain 
and abroad; the education of skilled support personnel; the integration of renowned   
scientists from abroad into Spanish research laboratories; coordination of the 
activities between the public research sector and the private research centres and 
firms. 
 
These broad objectives implied the intervention of three agencies. The main 
Agency was the Secretariat of the National R&D Plan involved directly in the 
funding of research projects and infrastructure as well as in the support of 
accompanying measures. The training and educational activities were managed by 
the General Directorate of Scientific and Technical Research (Ministry of 
Education and Science). The line related to innovation and technological 
development was run by CDTI.  
 
It is worth noting that the line of industrial links geared by CDTI held the lion´s 
share of the financial resources (52.4 per cent of the total funds of the programme). 
 
The three agencies involved in the R&D on pharmaceuticals programme acted 
according to path 1 of the model (fig.1). 
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b) Results 
 
b-1) The regional distribution following the same separation marks as in the Materials 
programme (see above) was: 
  
- Medium share: Comunidad Valenciana  (9%), Andalucía (7.7%), Canarias 
(7%), Castilla-León (5%). 
 
This distribution presents a marked differential profile with respect to that 
shown by the New Materials programme-incorporation of Galicia, Canarias and 
Castilla-León among the winners - and disparition  of Aragón. The important 
share in number of  projects and in funding by three universities (Santiago de 
Compostela (Galicia), La Laguna (Canarias) and Valencia (Comunidad  
Valenciana) who were the leaders, provide clues to this specific profile. 
 
b-2) Some conclusions about the products of the programme are: 
 
• Relevant contribution to production of knowledge but rather poor impact on the 
domains related to development and technological innovation. 
• The training of young researchers has been one of the relevant assets of the 
programme whereas the policies and criteria applied to the allocation of 
fellowships raised a great level of criticisms. A significant part of the trained 
scientists were incorporated in the public research sector (42%) and other  part 
(15%) were integrated in industries. 
• The priorities of the programme were both too broad in scope and far away 
from the interests of the Spanish pharmaceutical industries. The research was 
driven by curiosity-instead of being moved by the will to solve problems of 
practical relevance. 
• The Spanish pharmaceutical industries are not very prone to collaborate with 
the public research sector. They present divergent aims, interests and 
professional tracks. 
• The absence of skilled technical personnel flaws the research potential of the 
area in particular in connection with the applied aspects - clinical trials - of this 
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sector. The programme confirmed the need for it but was unable to correct for 
the deficits. 
• From the technological objectives prioritised by the programme, only three of 
them; "experimental and clinical pharmacology" (35 per cent), "drug systems 
designed through specific mechanisms and strategies" (27 per cent) and "search 
for new leader compounds of therapeutic interests" (19 per cent) have shown a 
reasonable  level of accomplishment. 
• The administrative bodies involved in the pharmaceutical policies (drug 
approval, prices settlement , regulations and norms) were not interested  or 
unaware of the research outcomes of the programme. This reveals a strong 
rupture in the coordination mechanisms and in the flow of knowledge 
production from the science base towards practical goals. 
• The success of the projects of industrial nature is only on average: there were a 
short number of projects and a small collaboration with the public sector. 
Among it , the hospitals, that were absent from the research realm, emerge as a 
new actors, though their funding was comparatively very low with that obtained 
by universities or CSIC from the collaborative projects with the industry. 
• The users of the programme show a different degree of satisfaction: research > 
industry > hospitals. 
 
 
3.1.3  The National Health Programme. 
 
The evaluation of this programme showed the same patterns and responded to the same 
forces driving the evaluation of the two former programmes. 
 
The instruments applied for the evaluation were the same as those applied to the other 
two programmes, albeit a differential feature resulted from the population of principal 
investigators and their affiliations. Among the 235 ones detected, 124 of  them (52.8 per 
cent) belonged to universities, 45(19 per cent) to CSIC, 44 (18.7 per cent) to hospital  
and 22 (9.4 per cent)  to other organisms (charities, foundations and centres adscribed to 
the National Health System). 
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There is a detailed publication on the evaluation of the Health Programme as Working 
Paper (Espinosa de los Monteros et al., 1995 b) as well as a synthesis paper (Espinosa 
de los Monteros et al. 1996). 
 
 
a) Structural Characteristics 
 
• The programme was targeted, like in the case of the R&D on Pharmaceuticals, with 
a broad objective and five aims of basic nature complemented with nine more 
precise technological objectives. 
• As in the former programmes, three agencies were involved in the implementation 
with the main role played by the Secretariat of the R&D National Plan, the other 
two being involved in the same type of activities and lines of action as stated for the 
R&D on Pharmaceuticals programme. Their way of action can then be assimilated 
to that of path 1 (model of fig.1). 
 
An interesting distinctive feature of the Health National Programme concerns the 
distribution of  sources; in this case, the lion´s share of the programme funds 
corresponded to research projects and infrastructure 76.6 per cent of the total) while 
the industrial related projects spent only the 13.5 per cent of it. 
 
 
b) Results 
 
b-1) The regional distribution profile shows marked differences with the other 
programmes analysed. 
- Main share: Madrid (41.8%), Cataluña (23.5 per cent), Andalucía (11.4%). 
- Medium share: Comunidad Valenciana (6.9%). 
This uneven share reflects the strength of the medical academia concentrated on 
universities and a certain number of hospitals (Hospital Clínico y Provincial de 
Barcelona, Hospital de la Santa Cruz y San Pablo (Barcelona), Hospital del Valle 
de Hebrón (Barcelona) as well as the importance of the regions (demography, 
quality of medical care, level of technologies applied to health) in the Spanish 
Health System. 
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b-2) The analysis of the results (outcomes) of  the programme has allowed to draw 
a series of conclusions similar to those outlined for the R&D on Pharmaceuticals 
Programme, but with some noteworthy specifities. 
• The contribution to the production of scientific knowledge has been relatively 
high (medium - high) but perhaps insufficient for the predominance of the 
research side in the frame of this programme on Health. 
• The good training of young research personnel (as an asset of the programme) 
contrasts with the poor use of these human resources in further research and 
technological careers. 
• The priorities of the programme were once more too broad and lacked focus. 
Only four one of the nine technological objectives " Health problems related to 
environment and health and life styles" with 31 per cent of the projects, Cancer" 
(24%), Immunology (11%), and Toxicology (10%)  have attained good records 
in accomplishment. The other five, some of them so relevant in scientific and 
social terms such as "Aids" " Health problems related to aging", "Human 
genome" and "Development of health technologies" received a testimonial 
attention from the demand side. 
• The objectives were far from the interests of industries. This together with the 
low level of resources devoted to industrially - oriented projects has led to a low 
participation of the Spanish firms in the programme. Only 12 businesses were 
involved in the programme through the period 1989-1993. Moreover, the 
collaboration of these firms with the main public organisations involved in the 
execution of the programme universities and CSIC was very low (seven 
universities and one institute from CSIC were involved in 11 collaborative 
projects out of  18, while the remaining 7 were performed in collaboration with 
hospitals). 
• Though some hospitals were players of the Health Programme, their 
representation was rather symbolic as compared with the research potential of 
these institutions (see below on the evaluation of the Health Research Fund, FIS 
from its acronym of the Spanish name Fondo de Investigación Sanitaria). 
• The lack of links between the research interests of the public sector and the 
industry was more than evident. This is particularly true for the CSIC centres - 
in spite of the relevance of the biomedical research area for this institution. 
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These points out to a basic structural problem in the shaping of  research on 
health carried out by the CSIC research laboratories. 
• The size and stability of the research groups involved in the execution of the 
Health Programme was smaller than in other National Programmes and this was 
denounced by 54 to 66 per cent of the researchers responding to the survey who 
considered that size and stability as insufficient for a goal research performance. 
• The administrative bodies responsible for the health policy in Spain (i. e, the 
Ministry of Health of and Consume and the Regional Authorities) did show 
moving away from the evolution and outcomes of the National R&D 
Programme on Health. 
 
3.2  The National Research Fund  ("Fondo de Investigación Sanitaria", FIS) 
 
This fund was created in 1980  relying on the tradition of a previous fund established in 
1968 which aimed to direct the 15 per cent of the allowance of the pharmaceutical 
industry to the Spanish Social Security System to promote research activities and to 
fund travel fellowships and scientific meetings. 
 
As José Ramón Ricoy, who was the first fully dedicated Director of the FIS, has 
pointed out (Ricoy, 1996), three periods can be distinguished in the history of FIS. The 
first period corresponded to the use for research in medicine of the funds from the 
industry (the so called "etapa del Descuento Complentario" "stage of the 
Complementary Discount") extending from 1968-1980. 
- The second period was through 1980-1987 on which the FIS was managed with 
a partially employed Director where the Funds began to build its identity. 
- The last period that began in April 1987 when the position of a fully dedicated 
Director was established. 
 
3.2.1 The evaluation project 
 
The evaluation exercise that was undertaken by our team focused on this third period 
(1988-1995) and responded to the driven forces of the responsible of  the agency who, 
at the end of 1995, decided it was time to develop a full exercise of evaluation of a 
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research programme for the first time of the short life of science and technology policy 
in Spain. 
 
The evaluation had to be funded through the figure of a research project since the statute 
of  FIS  made the agency unable to establish any contract. The project was articulated 
under the direction of E. Muñoz with a multidisciplinary team composed by medical 
doctors, biomedical researchers, social scientists. Some of them had been formerly 
involved in the political and scientific management of FIS, others had experience in 
bibliometrics and some other were experts in the analysis of public policies. An external 
panel (advisory committee) composed of relevant science practioners and policy makers 
was also established as a sort of monitoring control of the evolution of the project. 
 
The project was framed under the underlying idea of the "transducing model". In view 
of the complexity of the task the project aimed to define the structure of the programme 
and to analyse the functioning of the agency (the "transducing machinery") and the 
outcomes of this functioning (publications, impacts on the health system and/or  on the 
institution or centre where the research was performed, influence of research training 
and knowledge transfer on the careers of the professionals of the Spanish Health 
System). 
 
The basic search lines in the study were: 
- the information derived from the Annual Reports of FIS and its records and data 
bases, 
- the analysis of the call for proposals through the different years of the FIS 
activities and the breakdown of resources between the different lines of activity 
- the focus of the analysis on the research projects and the training scheme 
("Becas de Ampliación de Estudios", fellowships for enlargement of 
professional skills) 
- the follow-up of the allocation of resources through the different thematic areas 
as a way to explore the implicit or explicit political decisions underlying that 
allocation. 
- The correlation between the production of knowledge and the share of resources 
as a function of projects, organisation, regions as a means to analyse the 
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eventual influences - scientific, circunstantial, political - in he process of 
making decisions. 
- Search for the possible relationships between the objectives attained with the 
research projects and the health system; exploration of the impact. 
 
The desk analysis of  documents, surveys and interviews were the instruments 
used for the analytical development of the project. 
 
 
Results on the structure and function of FIS activities 
 
The work has permitted to obtain a wide set of results whose detailed presentation can 
not be the subject of the present report. Some of the results of the study are available as 
grey or public literature (Muñoz et al., 1999, Espinosa de los Monteros et al. 1999 a and 
b; Sanz-Menéndez and Diaz Benito, 2000). An outline of the main conclusions is as 
follows. 
• The R&D activities funded by the Spanish National Research Fund (FIS) did not 
correspond to a targeted, well-defined programme. The funding agency (FIS) 
behaved according to a pattern corresponding to path 2 of the model depicted in 
figure 1. 
• The share of resources was markedly influenced by the criteria of "excellence", 
relevance and power of the scientific community. So, regional, institutional and 
organisational distribution of the sources were mapping the most influential research 
communities ("Matthew effect"). 
• There is for the first time in the analyses of research programmes performed in 
Spain, the possibility to correlate the sources allocated by a funding agency with the 
research outcomes (bibliometric analysis). This allows to analyse the productivity 
(efficiency and efficacy) of a research programme by type of project, type of 
research, thematic area, institution or region. 
• The exercise carried out allowed for a contrast between the motivations and interest 
of the researchers performing that activity in hospitals with those of the hospital 
managers and administrative heads. 
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• The group in charge of the analysis of the training subprogramme led by Sanz-
Menéndez expressed criticisms about the methodology used because it made 
difficult to evaluate the causality of the public action. However, after using the 
survey method praised by us, they conclude that it was possible to detect processes 
situations and changes in the level of education and training of the users of the FIS 
subprogramme with (unavoidable) evidence. 
 
 
4 Some presumptive conclusions 
 
• We have discussed in theoretical terms and presented examples on the application of 
a methodology to evaluate R&D programmes that permit to obtain conclusions 
extending beyond the linear types of analysis based on the input/output approaches 
or on the arguments of causality followed by the proponents of the classical methods 
of evaluation of public policies. 
• The method proposed by us found its grounds in biology as a source of analogies 
while the former methods and models based on linearity found its base in the 
analogies with physics. 
• It is obvious that the methodology proposed by us can raise and it is going to raise 
criticisms. But science progresses and the scientific method proceeds by performing 
empirical analysis (experiment) and by raising criticism, and/or support to them. To 
stay attached with not totally convincing methodologies and approaches is to fight 
against the unavoidable path of progress. 
• The methods used by us, should they be referred simply as studies of the type of 
"public opinion polls", allow to draw attention to the evolution of R&D 
programmes, on how complex they are for an appropriate management, on how they 
can be (and are) influenced by several type of actors (producers and clients). In 
summary, they permit to approach the analysis of complexity thriving in an 
extremely complex social "milieu". 
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